// App-Quantinova.ai

OP0039 (2017) : A POPULATION-BASED STUDY ON MORTALITY AND THE INFLUENCE OF MEDICATION USE IN 4356 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND 21845 MATCHED CONTROLS FROM THE UNITED KINGDOM

Researchers

Presenter

  • I.E. Bultink

Principal Investigators

  • A. Lalmohamed

  • F. de Vries

Medical Centers

  • Amsterdam Rheumatology and Immunology Center, VU University Medical center, Amsterdam, Netherlands

  • Clinical Pharmacy, University Medical Center Utrecht

  • Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands

  • Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Lilly Netherlands

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved